A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

NCT07569042 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Neoplasm of Brain

Interventions

DRUG: NBM-BMX Capsule
DRUG: Temozolomide

Sponsor

Novelwise Pharmaceutical Corporation